JAK3 and glioblastoma: Disruption of the RXFP1‐JAK3‐STAT3 signaling cascade by specific KD or pharmacological inhibition abolished the CTRP8‐mediated increase in cellular Cdc42 protein levels and reduced the motility of patient GBM cells.